Retromer deficiency is also observed in postmortem AD brains and a disruption in retromer-mediated endosomal recycling results in altered APP metabolism and the loss of cell surface receptors that are critical for neuronal plasticity and synaptic health and thus, AD pathology [82,83]. The gene discussed is CD177; the disease is Alzheimer disease.